OxyContin maker Purdue Pharma is trying to chart the course for a new mass settlement of thousands of lawsuits over the toll of opioids after the U.S. Supreme Court last month rejected its previous deal, which was years in the making.
The threat of litigation looms as Purdue Pharma returns to settlement talks
OxyContin maker Purdue Pharma is trying to chart the course for a new mass settlement of thousands of lawsuits over the toll of opioids after the U.S. Supreme Court last month rejected its previous deal, which was years in the making.
State, local and tribal governments and individual victims want a sense of justice - and money.
And in this case, there’s not enough money to pay for all harms that are claimed. Most of what there is is held by members of the Sackler family who own Purdue - much of it in overseas trust funds that are protected from U.S. lawsuits.
Here’s a look at where things stand: